Apixaban Price Trend and Forecast

North America

In the third quarter of 2022, market growth was constrained, according to Apixaban price patterns. Due to a decrease in the supply of the API among manufacturers, Apixaban prices increased significantly in the North American market during the first half of Q3. The weak Apixaban market has been sustained by the meager downstream pharmaceutical demand. The US Federal Reserve's tight monetary policy and high-interest rates implemented around the end of the third quarter severely harmed the prospects for domestic commerce. Fears of a recession among traders have made the economic growth barriers stronger. The price of feedstock titanium dioxide among the dealers has also been negatively impacted by the declining price of crude oil. In the final phase of Q3 2022, the value accessed at USD 3250890/MT with an average quarterly declination of 1.43%.

Asia

In the Asia-Pacific region, the market for Apixaban has seen constricted market fundamentals. Apixaban's pricing dynamics have been significantly impacted by declining demand, rising inflation, and large supply, which has kept its market value low in the regional market. On the upstream price front, the declining Price of Titanium Dioxide has also caused a further decrease in the cost of producing Apixaban. The market feelings around Apixaban, however, were neutralized, and the traders' market value was supported near the end of the quarter by the muted demand from the downstream pharmaceuticals sector. The value accessed at the end of Q3 2022 was USD 2650450/MT, with an average quarterly decline of 3.27%.

Europe

During the third quarter of 2022, price trends of Apixaban gained a downward momentum in the European region. The supply turmoil unleashed by Russia's invasion of Ukraine has severely impacted trade activities across the globe. The upstream input material costs have also been reported on the lower end, prompting declining market sentiments for Apixaban. In addition, the ease in material tariffs and stabilizing fuel and transportation charges have also influenced the operating cost. At the termination of Q3 2022, the value accessed at USD 2924500/MT with an average quarterly declination of 0.65%. Thus, the depreciating costs have been passed on to the terminal consumer at improved prices throughout the third quarter.

ChemAnalyst addresses the key problematic areas and risks associated with chemical and petrochemical business globally and enables the decision-maker to make smart choices. It identifies and analyses factors such as geopolitical risks, environmental risks, raw material availability, supply chain functionality, disruption in technology and so on. It targets market volatility and ensures clients navigate through challenges and pitfalls in an efficient and agile manner. Timeliness and accuracy of data has been the core competency of ChemAnalyst, benefitting domestic as well as global industry in tuning in to the real-time data points to execute multi-billion-dollar projects globally.